|
MRPS30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.119100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.684600E-03 |
| Normal-vs-Stage2 |
7.624000E-01 |
| Normal-vs-Stage3 |
5.703200E-01 |
| Normal-vs-Stage4 |
7.705600E-01 |
| Stage1-vs-Stage2 |
1.061750E-01 |
| Stage1-vs-Stage3 |
4.106400E-01 |
| Stage1-vs-Stage4 |
4.738400E-01 |
| Stage2-vs-Stage3 |
5.319600E-01 |
| Stage2-vs-Stage4 |
6.907400E-01 |
| Stage3-vs-Stage4 |
9.023400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.097300E-03 |
| Normal-vs-AfricanAmerican |
7.104000E-02 |
| Normal-vs-Asian |
7.922000E-01 |
| Caucasian-vs-AfricanAmerican |
6.559200E-01 |
| Caucasian-vs-Asian |
7.207600E-01 |
| AfricanAmerican-vs-Asian |
8.321000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.643840E-04 |
| Normal-vs-Female |
7.454800E-01 |
| Male-vs-Female |
1.329850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.563400E-01 |
| Normal-vs-Extreme_Weight |
5.575600E-03 |
| Normal-vs-Obese |
5.739300E-03 |
| Normal-vs-Extreme_Obese |
7.145600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.868600E-01 |
| Normal_Weight-vs-Obese |
4.764800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.609000E-01 |
| Extreme_Weight-vs-Obese |
9.180200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.801200E-01 |
| Obese-vs-Extreme_Obese |
2.682000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.949640E-01 |
| Normal-vs-Age(41-60Yrs) |
9.780800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.169840E-02 |
| Normal-vs-Age(81-100Yrs) |
1.787860E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.842600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.543800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.558800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.655600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.871000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.338200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.08569999996067E-07 |
| Normal-VS-Type2 PRCC |
4.671200E-01 |
| Normal-VS-KIRP CIMP |
4.913600E-02 |
| Normal-VS-Unclassified PRCC |
9.609800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.788540E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.238400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.025200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.039900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.217800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.853800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.898300E-02 |
| Normal-vs-N1 |
3.515200E-01 |
| Normal-vs-N2 |
2.040800E-01 |
| N0-vs-N1 |
4.911400E-01 |
| N0-vs-N2 |
3.705400E-01 |
| N1-vs-N2 |
1.353840E-01 |
|
|
